Literature DB >> 26162866

Bidirectional Effect of Pregnenolone Sulfate on GluN1/GluN2A N-Methyl-D-Aspartate Receptor Gating Depending on Extracellular Calcium and Intracellular Milieu.

Divyan A Chopra1, Daniel T Monaghan1, Shashank M Dravid2.   

Abstract

Pregnenolone sulfate (PS), one of the most commonly occurring neurosteroids in the central nervous system, influences the function of several receptors. PS modulates N-methyl-D-aspartate receptors (NMDARs) and has been shown to have both positive and negative modulatory effects on NMDAR currents generally in a subtype-selective manner. We assessed the gating mechanism of PS modulation of GluN1/GluN2A receptors transiently expressed in human embryonic kidney 293 cells using whole-cell and single-channel electrophysiology. Only a modest effect on the whole-cell responses was observed by PS in dialyzed (nonperforated) whole-cell recordings. Interestingly, in perforated conditions, PS was found to increase the whole-cell currents in the absence of nominal extracellular Ca(2+), whereas PS produced an inhibition of the current responses in the presence of 0.5 mM extracellular Ca(2+). The Ca(2+)-binding DRPEER motif and GluN1 exon-5 were found to be critical for the Ca(2+)-dependent bidirectional effect of PS. Single-channel cell-attached analysis demonstrated that PS primarily affected the mean open time to produce its effects: positive modulation mediated by an increase in duration of open time constants, and negative modulation mediated by a reduction in the time spent in a long-lived open state of the receptor. Further kinetic modeling of the single-channel data suggested that the positive and negative modulatory effects are mediated by different gating steps which may represent GluN2 and GluN1 subunit-selective conformational changes, respectively. Our studies provide a unique mechanism of modulation of NMDARs by an endogenous neurosteroid, which has implications for identifying state-dependent molecules.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26162866      PMCID: PMC4576688          DOI: 10.1124/mol.115.100396

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  33 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons.

Authors:  Emmanuel Kostakis; Ming-Kuei Jang; Shelley J Russek; Terrell T Gibbs; David H Farb
Journal:  J Neurochem       Date:  2011-09-28       Impact factor: 5.372

3.  Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.

Authors:  Timothy M Acker; Hongjie Yuan; Kasper B Hansen; Katie M Vance; Kevin K Ogden; Henrik S Jensen; Pieter B Burger; Praseeda Mullasseril; James P Snyder; Dennis C Liotta; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2011-08-01       Impact factor: 4.436

4.  Neurosteroid binding to the amino terminal and glutamate binding domains of ionotropic glutamate receptors.

Authors:  Krasnodara Cameron; Emily Bartle; Ryan Roark; David Fanelli; Melissa Pham; Beth Pollard; Brian Borkowski; Sarah Rhoads; Joon Kim; Monica Rocha; Martha Kahlson; Melinda Kangala; Lisa Gentile
Journal:  Steroids       Date:  2012-04-03       Impact factor: 2.668

5.  Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids.

Authors:  M Park-Chung; F S Wu; R H Purdy; A A Malayev; T T Gibbs; D H Farb
Journal:  Mol Pharmacol       Date:  1997-12       Impact factor: 4.436

6.  Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles.

Authors:  Kevin Erreger; Shashank M Dravid; Tue G Banke; David J A Wyllie; Stephen F Traynelis
Journal:  J Physiol       Date:  2005-01-13       Impact factor: 5.182

7.  Neurosteroid modulation of recombinant ionotropic glutamate receptors.

Authors:  N Yaghoubi; A Malayev; S J Russek; T T Gibbs; D H Farb
Journal:  Brain Res       Date:  1998-08-24       Impact factor: 3.252

8.  Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.

Authors:  Christine E Marx; Jimmy Lee; Mythily Subramaniam; Attilio Rapisarda; Dianne C T Bautista; Edwin Chan; Jason D Kilts; Robert W Buchanan; Eu Pui Wai; Swapna Verma; Kang Sim; Jayaraman Hariram; Rajesh Jacob; Richard S E Keefe; Siow Ann Chong
Journal:  Psychopharmacology (Berl)       Date:  2014-07-17       Impact factor: 4.530

9.  Crystal structure of a heterotetrameric NMDA receptor ion channel.

Authors:  Erkan Karakas; Hiro Furukawa
Journal:  Science       Date:  2014-05-30       Impact factor: 47.728

10.  Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway.

Authors:  P Wong; Y Sze; C C R Chang; J Lee; X Zhang
Journal:  Transl Psychiatry       Date:  2015-03-17       Impact factor: 6.222

View more
  9 in total

1.  The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators.

Authors:  Kiran Sapkota; Kim Dore; Kang Tang; Mark Irvine; Guangyu Fang; Erica S Burnell; Roberto Malinow; David E Jane; Daniel T Monaghan
Journal:  Biochem Pharmacol       Date:  2018-11-29       Impact factor: 5.858

Review 2.  Progresses in GluN2A-containing NMDA Receptors and their Selective Regulators.

Authors:  Menghan Niu; Xin Yang; Yuanyuan Li; Yanping Sun; Long Wang; Jing Ha; Yinghua Xie; Zibin Gao; Changzheng Tian; Le Wang; Yongjun Sun
Journal:  Cell Mol Neurobiol       Date:  2022-01-03       Impact factor: 5.046

Review 3.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

4.  Visualizing pregnenolone sulfate-like modulators of NMDA receptor function reveals intracellular and plasma-membrane localization.

Authors:  Mariangela Chisari; Timothy J Wilding; Samuel Brunwasser; Kathiresan Krishnan; Mingxing Qian; Ann Benz; James E Huettner; Charles F Zorumski; Douglas F Covey; Steven Mennerick
Journal:  Neuropharmacology       Date:  2018-10-15       Impact factor: 5.250

5.  Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives.

Authors:  Kiran Sapkota; Mark W Irvine; Guangyu Fang; Erica S Burnell; Neil Bannister; Arturas Volianskis; Georgia R Culley; Shashank M Dravid; Graham L Collingridge; David E Jane; Daniel T Monaghan
Journal:  Neuropharmacology       Date:  2017-07-11       Impact factor: 5.250

6.  Dual action of amitriptyline on NMDA receptors: enhancement of Ca-dependent desensitization and trapping channel block.

Authors:  Yulia D Stepanenko; Sergei I Boikov; Dmitry A Sibarov; Polina A Abushik; Nina P Vanchakova; Daria Belinskaia; Natalia N Shestakova; Sergei M Antonov
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

Review 7.  Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.

Authors:  Erica S Burnell; Mark Irvine; Guangyu Fang; Kiran Sapkota; David E Jane; Daniel T Monaghan
Journal:  J Med Chem       Date:  2018-03-05       Impact factor: 7.446

8.  A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors.

Authors:  Divyan A Chopra; Kiran Sapkota; Mark W Irvine; Guangyu Fang; David E Jane; Daniel T Monaghan; Shashank M Dravid
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

9.  Pregnenolone Inhibits Osteoclast Differentiation and Protects Against Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss.

Authors:  Xiaochen Sun; Chenxi Zhang; Huan Guo; Jiao Chen; Yali Tao; Fuxiao Wang; Xixi Lin; Qian Liu; Li Su; An Qin
Journal:  Front Pharmacol       Date:  2020-03-27       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.